The Board of Directors of SKAN Group AG has proposed Dr. Christian Schlogel as a new member for election at the company's Annual General Meeting on May 7, 2026. This nomination follows the decision of Patrick Schar not to stand for re-election after 16 years of service on the board. The move underscores SKAN's strategic focus on expanding its digital capabilities within the pharmaceutical manufacturing sector.
Dr. Christian Schlogel brings over 30 years of leadership experience in global technology, software, and industrial companies, with a specific focus on digital transformation and artificial intelligence. His most recent role was as Group Chief Digital Officer and a member of the Executive Board at Korber AG from 2018 to 2025, where he led the digital transformation for a group of approximately 14,000 employees. Prior to that, from 2014 to 2018, he served as Group Chief Technology & Digital Officer at KUKA AG, an international automation and robotics group with around 15,000 employees. He began his career at SAP AG and holds advanced degrees in computer science and business administration.
Beat Lüthi, Chairman of the Board of Directors of SKAN Group, emphasized the strategic rationale behind the nomination. He stated that SKAN is expanding its offering to include software and digital integration services, a direction highlighted by the company's acquisition of a majority stake in Metronik last year. Lüthi explained that Dr. Schlogel's expertise is expected to significantly support these initiatives, which are core elements of the strategy for future sales and margin growth. The company is concurrently driving forward the digital transformation of its own operations and service offerings.
SKAN Group AG is a market and technology leader in providing high-quality, process-critical isolator systems for aseptic pharmaceutical drug filling. The company, which employs close to 1,700 people globally, serves as a key partner to the pharmaceutical and biotech industry, including Contract Manufacturing Organisations (CMOs) and research laboratories. Its strategic pivot towards software and digital services, as evidenced by the Metronik acquisition and now the board nomination, aims to enhance its lifecycle support and innovative solutions for clients worldwide. The original announcement can be viewed on www.newmediawire.com.
The departure of Patrick Schar, a financial expert who contributed significantly to SKAN's development over 16 years, marks a transition in the board's composition. Lüthi expressed gratitude for Schar's long-term commitment. For industry leaders and observers, this board nomination signals SKAN's commitment to embedding digital and AI expertise at the highest level of governance. This strategic alignment could accelerate the integration of smart technologies into pharmaceutical manufacturing processes, potentially setting new industry standards for efficiency, data integration, and sterile production support. The company's financial calendar indicates the publication of its 2025 annual results on March 24, 2026, preceding the Annual General Meeting.
